WNT signalling in prostate cancer

V Murillo-Garzón, R Kypta - Nature Reviews Urology, 2017 - nature.com
Genome sequencing and gene expression analyses of prostate tumours have highlighted
the potential importance of genetic and epigenetic changes observed in WNT signalling …

The oncogene ERG: a key factor in prostate cancer

P Adamo, MR Ladomery - Oncogene, 2016 - nature.com
ETS-related gene (ERG) is a member of the E-26 transformation-specific (ETS) family of
transcription factors with roles in development that include vasculogenesis, angiogenesis …

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing

T Fei, Y Chen, T **ao, W Li, L Cato, P Zhang… - Proceedings of the …, 2017 - pnas.org
Alternative RNA splicing plays an important role in cancer. To determine which factors
involved in RNA processing are essential in prostate cancer, we performed a genome-wide …

Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer

J Weischenfeldt, R Simon, L Feuerbach, K Schlangen… - Cancer cell, 2013 - cell.com
Early-onset prostate cancer (EO-PCA) represents the earliest clinical manifestation of
prostate cancer. To compare the genomic alteration landscapes of EO-PCA with" …

Genomic predictors of outcome in prostate cancer

PJ Boström, AS Bjartell, JWF Catto, SE Eggener… - European urology, 2015 - Elsevier
Context Given the highly variable behavior and clinical course of prostate cancer (PCa) and
the multiple available treatment options, a personalized approach to oncologic risk …

Molecular subtypes of prostate cancer

K Arora, CE Barbieri - Current Oncology Reports, 2018 - Springer
Abstract Purpose of Review This review will examine the taxonomy of PCa subclasses
across disease states, explore the relationship among specific alterations, and highlight …

Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes

SA Tomlins, M Alshalalfa, E Davicioni, N Erho… - European urology, 2015 - Elsevier
Abstract Background Prostate cancer (PCa) molecular subtypes have been defined by
essentially mutually exclusive events, including ETS gene fusions (most commonly involving …

BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence

L Gu, SC Frommel, CC Oakes, R Simon, K Grupp… - Nature …, 2015 - nature.com
Prostate cancer is driven by a combination of genetic and/or epigenetic alterations.
Epigenetic alterations are frequently observed in all human cancers, yet how aberrant …

Genome-wide DNA Methylation Events in TMPRSS2–ERG Fusion-Negative Prostate Cancers Implicate an EZH2-Dependent Mechanism with miR-26a …

ST Börno, A Fischer, M Kerick, M Fälth, M Laible… - Cancer …, 2012 - aacrjournals.org
Prostate cancer is the second most common cancer among men worldwide. Alterations in
the DNA methylation pattern can be one of the leading causes for prostate cancer formation …

Molecular pathways and targets in prostate cancer

E Shtivelman, TM Beer, CP Evans - Oncotarget, 2014 - pmc.ncbi.nlm.nih.gov
Prostate cancer co-opts a unique set of cellular pathways in its initiation and progression.
The heterogeneity of prostate cancers is evident at earlier stages, and has led to rigorous …